Cheli Melzer-Cohen

10PUBLICATIONS
31CO-AUTHORS
Major global burdens of diseaseNeurology and neuromuscular diseasesPredictive and prognostic markersEpidemiological modellingGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 27, 2026
Obesity in Late Adolescence and Healthcare Costs in Young to Mid-Adulthood.

|Apr 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.

Afif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit

|Nov 07, 2023
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study.

Irit Ben-Aharon, Ran Rotem, Cheli Melzer-Cohen

|Jun 29, 2023
Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data.

Meir Schechter, Cheli Melzer Cohen, Tamir Zelter

|Jun 29, 2023
Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease.

Cheli Melzer Cohen, Meir Schechter, Aliza Rozenberg

|Feb 11, 2023
Real-World Use of Alirocumab: Experience from a Large Healthcare Provider.

Avishay Elis, Cheli Melzer Cohen, Gabriel Chodick

Pageof 2

Frequent Collaborators

4 joint publications

Gabriel Chodik

2 joint publications

Ofri Mosenzon

2 joint publications

Meir Schechter

2 joint publications

Gilad Twig